DEC 16, 2020 6:00 AM PST

Gene Marker PACS a Punch for Cervical Cancer Treatments

WRITTEN BY: Tara Fernandes

In cervical cancer, mutations in healthy cells cause cells to grow and multiply uncontrollably, invading surrounding tissues and spreading around the body. Infection by the human papillomavirus (HPV) and lifestyle factors are among the root causes of the disease. In 2020, nearly 14,000 women in the U.S. will be diagnosed with invasive cervical cancer and over 4,000 will die from it.

Chemotherapy and radiation are standard clinical interventions for cervical cancer. However, the problem is that not every patient will respond favorably to these treatments. Until now, there is no way for physicians to distinguish which subset of patients will benefit from standard treatment strategies and which should opt for alternatives.

Now, cancer experts from UCLA have identified a gene called PACS-1, which when expressed at high levels in cervical cancer tissues, points towards possible resistance to chemo treatment. The scientists were able to track the dynamics of the PACS-1 protein in cells derived from primary tumors and made an interesting discovery. 

When the PACS-1 protein translocated from the cell’s cytoplasm to the nucleus, this made the cell resistant to killing by cancer therapeutics. This occurred through the PACS-1-mediated suppression of the DNA damage response — an in-built safety mechanism in cells that repairs DNA to prevent the generation of deleterious mutations.

The study, published in the Journal of Biological Chemistry, suggests that PACS-1 represents a viable diagnostic marker that could contribute to improved therapeutic strategies for patients with chemo-resistant cervical cancer. The authors suggest that treatments that suppress PACS-1 expression in combination with chemotherapeutics or immuno-oncology approaches might be the key to addressing these tumors which until now, have been deemed untreatable.


Source: Journal of Biological Chemistry.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
SEP 21, 2022
Immunology
Calorie Reduction Lowers Levels of Aging-Linked Proteins
SEP 21, 2022
Calorie Reduction Lowers Levels of Aging-Linked Proteins
A variety of studies have suggested that diets that restrict or reduce caloric intake can lengthen lifespan. Now, resear ...
SEP 21, 2022
Health & Medicine
Combined Birth Control Pill Has Serious Health Risk in Obese Women
SEP 21, 2022
Combined Birth Control Pill Has Serious Health Risk in Obese Women
Birth control pills are the leading method of birth control in the United States. Birth control pills increase the chanc ...
OCT 20, 2022
Cancer
Mast Cells Facilitate Metastasis in HR+ Breast Cancer
OCT 20, 2022
Mast Cells Facilitate Metastasis in HR+ Breast Cancer
The gut microbiome describes the microorganisms and viruses that live throughout the digestive system.  The gut mic ...
NOV 01, 2022
Cell & Molecular Biology
Understanding the Connection Between Stroke and Shingles
NOV 01, 2022
Understanding the Connection Between Stroke and Shingles
Shingles, or herpes zoster (HZ), is caused by the varicella zoster virus, which is the same virus that causes chicken po ...
NOV 28, 2022
Clinical & Molecular DX
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
NOV 28, 2022
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
MicroRNAs are small (between just 21 and 23 nucleotides), non-coding RNA molecules. They are involved in the post-transc ...
DEC 01, 2022
Genetics & Genomics
No more manual library preps!
DEC 01, 2022
No more manual library preps!
BioQuleTM NGS System - Say ‘goodbye’ to manual library prepping and ‘hello’ to generating librar ...
Loading Comments...